The 23rd Drug Information Association (DIA) Japan Annual Meeting 2026

The 23rd Drug Information Association (DIA) Japan Annual Meeting 2026 is organized by Drug Information Association (DIA) and will be held from Oct 18 - 20, 2026 at Tokyo Big Sight, Koto city, Tokyo, Japan.

Theme: “Crossing Boundaries, Shaping a Future Beyond Imagination with Innovation.”

Description:
Today, the fields of healthcare and pharmaceutical development are undergoing a transformation of unprecedented proportions.Rapid advances in digital technologies and artificial intelligence (AI), diversification of drug discovery and development models, open innovation, regulatory reforms, patient-centric approaches, engagement of diverse stakeholders, and the pursuit of sustainability and social value are all progressing simultaneously — ushering in an era of change unlike any before.

Medicine and healthcare have been traditionally confined to biological and chemical domains. In recent years, however, collaboration with engineering and information technology (IT) has accelerated, and integration with human and social sciences—such as addressing ELSI (ethical, legal, and social issues)—has become indispensable. The concept of “Neue Kombinationen” (literally “new combination,” rendered as “innovation”) proposed by economist Joseph Schumpeter refers not merely to invention or technological innovation, but to the creative act of combining existing elements in new ways. Such “new combinations” drive discontinuous change (what Schumpeter called “creative destruction”), bringing new value to society and industry.

In today’s world, connecting knowledge and technologies across disciplines through “innovation ” is more critical than ever. While AI has dramatically improved the efficiency of information processing and output, what AI generates remains an extension of existing knowledge and patterns. Therefore, creative attempts to combine existing elements in unprecedented ways represent a uniquely human endeavor—one that may hold the key to shaping the future in the AI era.

The 23rd DIA Japan Annual Meeting provides a forum where participants from diverse fields, roles, organizations, and countries come together to explore possibilities beyond imagination through “innovation” born of interdisciplinary collaboration. We hope that each participant will bring their expertise and experience, engage in discussion and cooperation across disciplines, and seize this opportunity to open new horizons in healthcare and pharmaceutical development.